RxDoctor Payments Data

Jeffrey Bruening, DPM

Podiatrist · Covina, CANPI 1730264698

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Fusion Orthopedics USA, LLC at 45.3% of the total. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,823in general payments, 2019–2025

Across 237 payments — averaging $104.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fusion Orthopedics USA, LLC$11K
  • Treace Medical Concepts, Inc.$3K
  • Arthrex$2K
  • Sportstek Medical, Inc$2K
  • Paragon 28, Inc.$2K
  • Stryker$2K
  • plus $4K from 28 others

What the payments were for

  • Consulting fees$10,37542%
  • Travel & lodging$6,62327%
  • Food & beverage$6,32425%
  • Education$1,5006%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,823 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.

See all podiatrist providers in California

Medicare billing

Part B allowed, 2024
$147,270
Medicare patients
252
Services billed
1,255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox46$1,027
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$324
Terbinafine Hcl26$286
Gabapentin19$192
Ibuprofen11$172
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$85

Paid to pharmacies, not to this prescriber.

Other podiatrist in Covina

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →